Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3061850 20 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Design and synthesis of new adamantyl-substituted antileishmanial ether phospholipids
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
A series of new 2-[3-(2-alkyloxy-ethyl)-adamantan-1-yl]-ethoxy substituted ether phospholipids was synthesized and their antileishmanial activity was evaluated against Leishmania infantum amastigotes. The majority of the new analogues were significantly less cytotoxic than miltefosine while, antiparasitic activity depended on the length of the 2-alkyloxy substituent. The most potent compounds were 2-[[[3-(2-hexyloxy-ethyl)-adamant-1-yl]-ethoxy] hydroxyphosphinyloxy]ethyl-Ν,Ν,Ν-trimethyl-ammonium inner salt (5b) and 2-[[[3-(2-octyloxy-ethyl)-adamant-1-yl]-ethoxy]hydroxyphosphinyloxy]ethyl- Ν,Ν,Ν-trimethyl-ammonium inner salt (5c). © 2010 Elsevier Ltd. All rights reserved.
Έτος δημοσίευσης:
2010
Συγγραφείς:
Papanastasiou, I.
Prousis, K.C.
Georgikopoulou, K.
Pavlidis, T.
Scoulica, E.
Kolocouris, N.
Calogeropoulou, T.
Περιοδικό:
Bioorganic and Medicinal Chemistry Letters
Τόμος:
20
Αριθμός / τεύχος:
18
Σελίδες:
5484-5487
Λέξεις-κλειδιά:
[2 [[[3 (2 hexyloxy ethyl) adamant 1 yl] ethoxy] hydroxyphosphinyloxy] ethyl] n,n,n trimethyl ammonium inner salt; [2 [[[3 (2 octyloxy ethyl) adamant 1 yl] ethoxy] hydroxyphosphinyloxy] ethyl] n,n,n trimethyl ammonium inner salt; antileishmanial agent; miltefosine; phospholipid derivative; unclassified drug, amastigote; amino acid substitution; antileishmanial activity; article; controlled study; drug activity; drug cytotoxicity; drug design; drug synthesis; Leishmania infantum; macrophage activation; nonhuman, Antiprotozoal Agents; Cell Line; Cell Survival; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Phospholipid Ethers; Phosphorylcholine, Leishmania infantum
Επίσημο URL (Εκδότης):
DOI:
10.1016/j.bmcl.2010.07.078
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.